<SEC-DOCUMENT>0001213900-17-012849-index.html : 20171201 <SEC-HEADER>0001213900-17-012849.hdr.sgml : 20171201 <ACCEPTANCE-DATETIME>20171201162236 ACCESSION NUMBER: 0001213900-17-012849 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171201 DATE AS OF CHANGE: 20171201 GROUP MEMBERS: ENRICO CAVAZZA GROUP MEMBERS: FRANCESCA CAVAZZA GROUP MEMBERS: LEADIANT BIOSCIENCES, INC. GROUP MEMBERS: MARTINA CAVAZZA PRETA GROUP MEMBERS: PAOLO CAVAZZA GROUP MEMBERS: SILVIA CAVAZZA SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-39976 FILM NUMBER: 171234434 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE C-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Essetifin SPA CENTRAL INDEX KEY: 0001092601 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: VIA SUDAFRICA 20 CITY: ROME STATE: L6 ZIP: 00144 FORMER COMPANY: FORMER CONFORMED NAME: SIGMA TAU FINANZIARIA SPA DATE OF NAME CHANGE: 20030516 FORMER COMPANY: FORMER CONFORMED NAME: SIGMA TAU FINANZIARIA DATE OF NAME CHANGE: 19990805 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13D/A <SEQUENCE>1 <FILENAME>sc13d1117a5essetif_soligenix.htm <DESCRIPTION>AMENDMENT NO. 5 TO SCHEDULE 13D <TEXT> Document 1 - file: sc13d1117a5essetif_soligenix.htm
</DOCUMENT> </SEC-DOCUMENT>